黃亮，準聘副教授，主任醫師，博士研究生導師。任中國醫學科學院血液病醫院臨床研究平臺負責人、病區主任、PI。獲科技部重點研發專項課題、“863計劃”青年科學家專題、國家自然科學基金面上項目、中國醫學科學院醫學與健康科技創新工程項目等資助。曾入選首期“楚天英才·湖北省青年拔尖人才計劃”。 院校引進人才，2024年加入院校。曾在華中科技大學同濟醫學院附屬同濟醫院任副教授、主任醫師，并擔任血液內科副主任等職務。

長期從事淋巴系統腫瘤的精準診療和臨床轉化研究，包括：1. 系統解析免疫治療中免疫效應和炎癥反應的影響因素與機制，旨在突破免疫治療失敗與不良反應兩大臨床瓶頸；2. 侵襲性淋巴瘤、EBV相關淋巴增殖性疾病的發病機制與精準診療；3. 免疫、基因編輯等個性化創新療法的臨床轉化研究。

久久综合九色欧美综合狠狠_伊人热热久久原色播放WWW_成A人片亚洲日本久久_久久不见久久见免费影院www日本_97久久精品人人做人人爽,又色又爽又黄的视频在线观看,狼群影院视频在线观看高清版,亚洲AV无码精品网站性色,国产乱码久久久久久红粉影视,精品国产乱码久久久久久一区二区,国产精品免费视频网站,国产A级毛片久久久久久精品,一级特黄高清aaaa大片,亚洲中文字幕欧美一区,久久精品国产99久久狂热,黑人巨大精品欧美_黑人巨大精品欧美黑寡妇_黑人巨大精品欧美一区二区_黑人巨大精品欧美一区二区免费_黑人巨大跨种族video_黑人巨大无码中文字幕无码_黑人巨茎大战俄罗斯美女_黑人巨茎大战俄罗斯美女,中文字幕av不卡|亚洲欧美国产另类|天天干在线播放|日韩黄视频|欧美七区|可以免费看毛片的网站|黄色片在线|国产精品96久久久久久

(1) Cheng J^#, Hu X^#, Dai Z^#, Zeng Y, Jin J, Mu W, Wei Q, Jia X, Liu J, Xie M, Luo Q, Hu G, Wang G, Zhu X, Zhou J, Xiao M, Wang J^*, Tan T^*, Huang L^*. Targeting intracellular LMP2 with costimulatory signal-armed antibody-like TCR T cells. JCI Insight. 2025 May 22;10(10):e178572.

(2) Cheng Y^#, Zhang J^#, Mu W^#, Ye S, Cheng J, Zhu L, Wang G, Cao Y, Li D, Hu G^*, Huang L^*, Wang J^*, Zhou J. Dasatinib-resistant universal CAR-T cells proliferate in the presence of host immune cells and exhibit antitumor activity. Mol Ther. 2025 Apr 2;33(4):1535-1551.

(3) Li Z^#*, Zhao L^#, Zhang Y, Zhu L, Mu W, Ge T, Jin J, Tan J, Cheng J, Wang J, Wang N, Zhou X, Chen L, Chang Z, Liu C, Bian Z, Liu B^*, Ye L^*, Lan Y^*, Huang L^*, Zhou J. Functional Diversification and Dynamics of CAR-T Cells in B-ALL Patients. Cell Rep. 2023 Oct 31;42(10):113263.

(4) Li H^#, Yang X, Wang Z, She W, Liu Y^*, Huang L^*, Jiang P^*. A Near-Infrared-II Fluorescent Nanocatalyst for Enhanced CAR T Cell Therapy against Solid Tumor by Immune Reprogramming. ACS Nano. 2023 Jun 27;17(12):11749-11763.

(5) Tang Y^#, Xu Q^#, Luo H^#, Yan X, Wang G, Hu L, Jin J, Witte DP, Marsh RA, Huang L^*, Huang G^*, Zhou J^*. Excessive IL-10 and IL-18 trigger hemophagocytic lymphohistiocytosis-like hyperinflammation and enhanced myelopoiesis. J Allergy Clin Immunol. 2022 Nov;150(5):1154-1167.

(6) Wei J^#, Xiao M^#, Mao Z^#, Wang N, Cao Y, Xiao Y, Meng F, Sun W, Wang Y, Yang X, Chen L, Zhang Y, Zhu H, Zhang S, Zhang T, Zhou J^*, Huang L^*. Outcome of aggressive B-cell lymphoma with TP53 alterations administered with CAR T-cell cocktail alone or in combination with ASCT. Signal Transduct Target Ther. 2022 Apr 11;7(1):101.

(7) Cao W^#, Wei J^#, Wang N, Xu H, Xiao M, Huang L, Cao Y, Li C, Xiao Y, Gu C, Zhang S, Li D, Zhang Y, Zhang T, Zhou J^*, Huang L^*. Entecavir Prophylaxis for Hepatitis B Virus Reactivation in Patients with CAR T-cell Therapy. Blood. 2020 Jul 23;136(4):516-519.

(8) Wang N^#, Hu X^#, Cao W, Li C, Xiao Y, Cao Y, Gu C, Zhang S, Chen L, Cheng J, Wang G, Zhou X, Zheng M, Mao X, Jiang L, Wang D, Wang Q, Lou Y, Cai H, Yan D, Zhang Y, Zhang T, Zhou J^*, Huang L^*. Efficacy and Safety of CAR19/22 T-cell Cocktail Therapy in Patients with Refractory/Relapsed B-Cell Malignancies. Blood. 2020 Jan 2;135(1):17-27.

(9) Huang L^#, Liu D^#, Wang N^#, Ling S^#, Tang Y^#, Wu J, Hao L, Luo H, Hu X, Sheng L, Zhu L, Wang D, Luo Y, Shang Z, Xiao M, Mao X, Zhou K, Cao L, Dong L, Zheng X, Sui P, He J, Mo S, Yan J, Ao Q, Qiu L, Zhou H, Liu Q, Zhang H, Li J, Jin J, Fu L, Zhao W, Chen J, Du X, Qing G, Liu H, Liu X, Huang G, Ma D, Zhou J^*, Wang QF^*. Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia. Cell Res. 2018 Feb;28(2):172-186.

(10) Tang YT^#, Wang D^#, Luo H^#, Xiao M, Zhou HS, Liu D, Ling SP, Wang N, Hu XL, Luo Y, Mao X, Ao QL, Huang J, Zhang W, Sheng LS, Zhu LJ, Shang Z, Gao LL, Zhang PL, Zhou M, Zhou KG, Qiu LG, Liu QF, Zhang HY, Li JY, Jin J, Fu L, Zhao WL, Chen JP, Du X, Huang G, Wang QF, Zhou JF^*, Huang L^*. Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes. Blood Cancer J. 2017 Dec 21;7(12):660.